Merck (MRK) ended the recent trading session at $86.32, demonstrating a +1.8% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 1.07%. On the ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That’s a compound annual growth rate ...

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in ...

Merck & Co., Inc. has been catching eyes with its recent stock price movements. Despite a slight dip last week, the overall ...

Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an ...